By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Plasticell today said that it has been collaborating with regenerative medicine firm Stemnion to develop protocols for stem cell differentiation.

UK-based Plasticell used its CombiCult technology to discover "multiple novel, serum-free protocols that direct the differentiation of Stemnion's stem cells into hard-to-obtain lineages." Plasticell ranked the protocols using Ariadne's bioinformatics software, and Stemnion validated the protocols.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.